Difference between revisions of "LncRNAWiki:Featured"
| Line 11: | Line 11: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267755 HSALNT0267755] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0267755 HSALNT0267755] | ||
|[[LINC02597]] | |[[LINC02597]] | ||
| + | |_ | ||
|Transcriptional regulation | |Transcriptional regulation | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Postmenopausal osteoporosis (PMOP) | |Postmenopausal osteoporosis (PMOP) | ||
| Line 19: | Line 19: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0178412 HSALNT0178412] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0178412 HSALNT0178412] | ||
|[[UVRAG-DT]] | |[[UVRAG-DT]] | ||
| + | |_ | ||
|Transcriptional regulation | |Transcriptional regulation | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Postmenopausal osteoporosis (PMOP) | |Postmenopausal osteoporosis (PMOP) | ||
| Line 51: | Line 51: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021052 HSALNT0021052] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0021052 HSALNT0021052] | ||
|[[MIR205HG]] | |[[MIR205HG]] | ||
| + | |_ | ||
|CeRNA | |CeRNA | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Head & neck squamous cell carcinoma (HNSCC) | |Head & neck squamous cell carcinoma (HNSCC) | ||
| Line 59: | Line 59: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107588 HSALNT0107588] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0107588 HSALNT0107588] | ||
|[[ZNF451-AS1]] | |[[ZNF451-AS1]] | ||
| + | |_ | ||
|Transcriptional regulation | |Transcriptional regulation | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Pancreatic ductal adenocarcinoma (PDAC) | |Pancreatic ductal adenocarcinoma (PDAC) | ||
| Line 83: | Line 83: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0158500 HSALNT0158500] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0158500 HSALNT0158500] | ||
|[[LINC00707]] | |[[LINC00707]] | ||
| + | |_ | ||
|Transcriptional regulation | |Transcriptional regulation | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Lung cancer (LC) | |Lung cancer (LC) | ||
| Line 107: | Line 107: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123915 HSALNT0123915] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0123915 HSALNT0123915] | ||
|[[LINC02604]] | |[[LINC02604]] | ||
| + | |_ | ||
|CeRNA | |CeRNA | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Glioblastoma | |Glioblastoma | ||
| Line 115: | Line 115: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0160932 HSALNT0160932] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0160932 HSALNT0160932] | ||
|[[MACORIS]] | |[[MACORIS]] | ||
| + | |_ | ||
|Transcriptional regulation | |Transcriptional regulation | ||
| − | |||
|_ | |_ | ||
|Cardiometabolic Diseases | |Cardiometabolic Diseases | ||
| Line 123: | Line 123: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171022 HSALNT0171022] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0171022 HSALNT0171022] | ||
|[[KRTAP5-AS1]] | |[[KRTAP5-AS1]] | ||
| + | |_ | ||
|CeRNA | |CeRNA | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Gastric Cancer | |Gastric Cancer | ||
| Line 139: | Line 139: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072605 HSALNT0072605] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0072605 HSALNT0072605] | ||
|[[CHAER1]] | |[[CHAER1]] | ||
| + | |_ | ||
|Translational control | |Translational control | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Cardiac hypertrophy | |Cardiac hypertrophy | ||
| Line 147: | Line 147: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027291 HSALNT0027291] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0027291 HSALNT0027291] | ||
|[[ODC1-DT]] | |[[ODC1-DT]] | ||
| + | |_ | ||
|CeRNA | |CeRNA | ||
| − | |||
|Pathogenic process | |Pathogenic process | ||
|Head and neck carcinoma | |Head and neck carcinoma | ||
| Line 163: | Line 163: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208284 HSALNT0208284] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0208284 HSALNT0208284] | ||
|[[ZFHX2-AS1]] | |[[ZFHX2-AS1]] | ||
| + | |_ | ||
|Transcriptional regulation | |Transcriptional regulation | ||
| − | |||
|Developmental process | |Developmental process | ||
|_ | |_ | ||
| Line 387: | Line 387: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0172266 HSALNT0172266] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0172266 HSALNT0172266] | ||
|[[LINC00958]] | |[[LINC00958]] | ||
| + | |_ | ||
|protein localization,transcriptional regulation | |protein localization,transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|bladder cancer, glioma | |bladder cancer, glioma | ||
| Line 395: | Line 395: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167574 HSALNT0167574] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167574 HSALNT0167574] | ||
|[[SH3PXD2A-AS1]] | |[[SH3PXD2A-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| Line 403: | Line 403: | ||
|_ | |_ | ||
|[[SSTR5-AS1]] | |[[SSTR5-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|neuroendocrine prostate cancer | |neuroendocrine prostate cancer | ||
| Line 419: | Line 419: | ||
|_ | |_ | ||
|[[LINC00174]] | |[[LINC00174]] | ||
| + | |_ | ||
|ceRNA | |ceRNA | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|colorectal carcinoma | |colorectal carcinoma | ||
| Line 427: | Line 427: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0169064 HSALNT0169064] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0169064 HSALNT0169064] | ||
|[[LINC01561]] | |[[LINC01561]] | ||
| + | |_ | ||
|ceRNA | |ceRNA | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| Line 435: | Line 435: | ||
|_ | |_ | ||
|[[LINC00514]] | |[[LINC00514]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|neuroendocrine prostate cancer | |neuroendocrine prostate cancer | ||
| Line 459: | Line 459: | ||
|_ | |_ | ||
|[[LINC01567]] | |[[LINC01567]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|colon cancer | |colon cancer | ||
| Line 467: | Line 467: | ||
|_ | |_ | ||
|[[ADPGK-AS1]] | |[[ADPGK-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|pancreatic cancer | |pancreatic cancer | ||
| Line 475: | Line 475: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0255381 HSALNT0255381] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0255381 HSALNT0255381] | ||
|[[RAB11B-AS1]] | |[[RAB11B-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| Line 483: | Line 483: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237805 HSALNT0237805] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0237805 HSALNT0237805] | ||
|[[SNHG29]] | |[[SNHG29]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|acute myeloid leukemia, rheumatoid arthritis | |acute myeloid leukemia, rheumatoid arthritis | ||
| Line 491: | Line 491: | ||
|_ | |_ | ||
|[[SNHG17]] | |[[SNHG17]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|colorectal cancer | |colorectal cancer | ||
| Line 499: | Line 499: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215138 HSALNT0215138] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0215138 HSALNT0215138] | ||
|[[DICER1-AS1]] | |[[DICER1-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|osteosarcoma | |osteosarcoma | ||
| Line 507: | Line 507: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043929 HSALNT0043929] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0043929 HSALNT0043929] | ||
|[[TTN-AS1]] | |[[TTN-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|esophageal squamous cell carcinoma | |esophageal squamous cell carcinoma | ||
| Line 515: | Line 515: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152594 HSALNT0152594] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0152594 HSALNT0152594] | ||
|[[LINC00092]] | |[[LINC00092]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|ovarian cancer | |ovarian cancer | ||
| Line 523: | Line 523: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050704 HSALNT0050704] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0050704 HSALNT0050704] | ||
|[[THUMPD3-AS1]] | |[[THUMPD3-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Neuron death in stroke | |Neuron death in stroke | ||
| Line 531: | Line 531: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205980 HSALNT0205980] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0205980 HSALNT0205980] | ||
|[[LINC00554]] | |[[LINC00554]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| Line 539: | Line 539: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0141703 HSALNT0141703] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0141703 HSALNT0141703] | ||
|[[ZFPM2-AS1]] | |[[ZFPM2-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|multiple cancers, gastric carcinogenesis | |multiple cancers, gastric carcinogenesis | ||
| Line 547: | Line 547: | ||
|_ | |_ | ||
|[[HOXB-AS1]] | |[[HOXB-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|autosomal dominant polycistic kidney disease | |autosomal dominant polycistic kidney disease | ||
| Line 555: | Line 555: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167650 HSALNT0167650] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0167650 HSALNT0167650] | ||
|[[CFAP58-DT]] | |[[CFAP58-DT]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|innate immune response to viral infection | |innate immune response to viral infection | ||
| Line 571: | Line 571: | ||
|_ | |_ | ||
|[[CPNE8-AS1]] | |[[CPNE8-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|cervical cancer | |cervical cancer | ||
| Line 579: | Line 579: | ||
|_ | |_ | ||
|[[THORLNC]] | |[[THORLNC]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma | |melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma | ||
| Line 587: | Line 587: | ||
|_ | |_ | ||
|[[IATPR]] | |[[IATPR]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|breast cancer, gallbladder cancer | |breast cancer, gallbladder cancer | ||
| Line 595: | Line 595: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242280 HSALNT0242280] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0242280 HSALNT0242280] | ||
|[[PICART1]] | |[[PICART1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|breast cancer, colorectal cancer, lung cancer | |breast cancer, colorectal cancer, lung cancer | ||
| Line 603: | Line 603: | ||
|_ | |_ | ||
|[[LINC02599]] | |[[LINC02599]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|breast cancer | |breast cancer | ||
| Line 611: | Line 611: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183231 HSALNT0183231] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0183231 HSALNT0183231] | ||
|[[ETS1-AS1]] | |[[ETS1-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|gastric cancer, neuroblastoma | |gastric cancer, neuroblastoma | ||
| Line 619: | Line 619: | ||
|_ | |_ | ||
|[[MAPK6-DT]] | |[[MAPK6-DT]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|liver cancer | |liver cancer | ||
| Line 627: | Line 627: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0036655 HSALNT0036655] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0036655 HSALNT0036655] | ||
|[[IL1R1-AS1]] | |[[IL1R1-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Oral squamous cell carcinoma, breast cancer | |Oral squamous cell carcinoma, breast cancer | ||
| Line 635: | Line 635: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001134 HSALNT0001134] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001134 HSALNT0001134] | ||
|[[LINC01672]] | |[[LINC01672]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
| Esophageal squamous cell carcinoma | | Esophageal squamous cell carcinoma | ||
| Line 643: | Line 643: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135857 HSALNT0135857] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135857 HSALNT0135857] | ||
|[[SIRLNT]] | |[[SIRLNT]] | ||
| + | |_ | ||
|ceRNA | |ceRNA | ||
| − | |||
|pathogenic process | |pathogenic process | ||
| Breast cancer | | Breast cancer | ||
| Line 651: | Line 651: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135484 HSALNT0135484] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0135484 HSALNT0135484] | ||
|[[LINC01605]] | |[[LINC01605]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Colon Cancer, Bladder cancer | |Colon Cancer, Bladder cancer | ||
| Line 659: | Line 659: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184552 HSALNT0184552] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0184552 HSALNT0184552] | ||
|[[GAU1]] | |[[GAU1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Neuroblastoma and retinoblastoma | |Neuroblastoma and retinoblastoma | ||
| Line 667: | Line 667: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287294 HSALNT0287294] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0287294 HSALNT0287294] | ||
|[[LINC00894]] | |[[LINC00894]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Lung adenocarcinoma | |Lung adenocarcinoma | ||
| Line 691: | Line 691: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022481 HSALNT0022481] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022481 HSALNT0022481] | ||
|[[LINC01705]] | |[[LINC01705]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| Line 699: | Line 699: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022477 HSALNT0022477] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0022477 HSALNT0022477] | ||
|[[LINC02474]] | |[[LINC02474]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| Line 707: | Line 707: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030809 HSALNT0030809] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0030809 HSALNT0030809] | ||
|[[LINC02590]] | |[[LINC02590]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|gastric cancer | |gastric cancer | ||
| Line 715: | Line 715: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170966 HSALNT0170966] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0170966 HSALNT0170966] | ||
|[[MUC5B-AS1]] | |[[MUC5B-AS1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
| lung adenocarcinoma | | lung adenocarcinoma | ||
| Line 779: | Line 779: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103387 HSALNT0103387] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0103387 HSALNT0103387] | ||
|[[HCG14]] | |[[HCG14]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Celiac disease, Nutritional and Metabolic Diseases | |Celiac disease, Nutritional and Metabolic Diseases | ||
| Line 787: | Line 787: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001419 HSALNT0001419] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0001419 HSALNT0001419] | ||
|[[LNCTAM34A]] | |[[LNCTAM34A]] | ||
| + | |_ | ||
|ceRNA | |ceRNA | ||
| − | |||
|developmental process | |developmental process | ||
|Colon Cancer | |Colon Cancer | ||
| Line 795: | Line 795: | ||
|_ | |_ | ||
|[[LINC01510]] | |[[LINC01510]] | ||
| + | |_ | ||
|transcriptional regulation, ceRNA | |transcriptional regulation, ceRNA | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Colorectal cancer, Non-small cell lung cancer | |Colorectal cancer, Non-small cell lung cancer | ||
| Line 803: | Line 803: | ||
|_ | |_ | ||
|[[LNCOC1]] | |[[LNCOC1]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Ovarian cancer | |Ovarian cancer | ||
| Line 811: | Line 811: | ||
|_ | |_ | ||
|[[LGALSL-DT]] | |[[LGALSL-DT]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Postmenopausal osteoporosis (PMOP) | |Postmenopausal osteoporosis (PMOP) | ||
| Line 819: | Line 819: | ||
|[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002862 HSALNT0002862] | |[https://bigd.big.ac.cn/lncbook/transcript?transid=HSALNT0002862 HSALNT0002862] | ||
|[[LINC02596]] | |[[LINC02596]] | ||
| + | |_ | ||
|transcriptional regulation | |transcriptional regulation | ||
| − | |||
|pathogenic process | |pathogenic process | ||
|Postmenopausal osteoporosis (PMOP) | |Postmenopausal osteoporosis (PMOP) | ||
Revision as of 06:31, 29 August 2019
| LncBook ID | Symbol | Synonyms | Functional Mechanism | Biological Process | Disease | Mesh Ontology |
|---|---|---|---|---|---|---|
| HSALNT0267755 | LINC02597 | _ | Transcriptional regulation | Pathogenic process | Postmenopausal osteoporosis (PMOP) | Musculoskeletal Diseases |
| HSALNT0178412 | UVRAG-DT | _ | Transcriptional regulation | Pathogenic process | Postmenopausal osteoporosis (PMOP) | Musculoskeletal Diseases |
| HSALNT0185540 | LINC02598 | _ | _ | Pathogenic process | Lung squamous cell carcinoma (LUSC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0278274 | SREBF2-AS1 | _ | _ | Pathogenic process | Lung squamous cell carcinoma (LUSC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0021177 | LINC02602 | _ | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0021052 | MIR205HG | _ | CeRNA | Pathogenic process | Head & neck squamous cell carcinoma (HNSCC) | Neoplasms |
| HSALNT0107588 | ZNF451-AS1 | _ | Transcriptional regulation | Pathogenic process | Pancreatic ductal adenocarcinoma (PDAC) | Neoplasms |
| HSALNT0189537 | SCAT2 | _ | _ | Pathogenic process | Kidney clear cell carcinoma (KIRC) | Neoplasm |
| HSALNT0107867 | SCAT8 | _ | _ | Pathogenic process | Kidney clear cell carcinoma (KIRC) | Neoplasm |
| HSALNT0158500 | LINC00707 | _ | Transcriptional regulation | Pathogenic process | Lung cancer (LC) | Neoplasms; Respiratory Tract Diseases |
| HSALNT0185476 | LINC02470 | _ | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) and overian cancer | Neoplasm |
| HSALNT0068302 | LINC02600 | _ | _ | Pathogenic process | Non-small cell lung cancer (NSCLC) and overian cancer | Neoplasm |
| HSALNT0123915 | LINC02604 | _ | CeRNA | Pathogenic process | Glioblastoma | Neoplasms |
| HSALNT0160932 | MACORIS | _ | Transcriptional regulation | _ | Cardiometabolic Diseases | Cardiovascular Diseases |
| HSALNT0171022 | KRTAP5-AS1 | _ | CeRNA | Pathogenic process | Gastric Cancer | Neoplasms; Digestive System Diseases |
| HSALNT0215076 | GSC-DT | _ | _ | Developmental process | _ | _ |
| HSALNT0072605 | CHAER1 | _ | Translational control | Pathogenic process | Cardiac hypertrophy | Cardiovascular Diseases |
| HSALNT0027291 | ODC1-DT | _ | CeRNA | Pathogenic process | Head and neck carcinoma | Neoplasm |
| HSALNT0039409 | MAP3K2-DT | _ | _ | Pathogenic process | Polycystic ovary syndrome (PCOS) | Female Urogenital Diseases and Pregnancy Complications |
| HSALNT0208284 | ZFHX2-AS1 | _ | Transcriptional regulation | Developmental process | _ | _ |
| HSALNT0152349 | LINC02603 | _ | _ | _ | _ | _ |
| HSALNT0081596 | TENM3-AS1 | _ | _ | _ | _ | _ |
| HSALNT0165522 | LINC00858 | _ | _ | _ | non-small cell lung cancer | Respiratory Tract Diseases |
| HSALNT0281930 | SCAT1 | _ | _ | _ | esophagal cancer | Digestive system Diseases |
| HSALNT0191750 | LNCOG | _ | _ | _ | osteogenic differenciation | Musculoskeletal Diseases |
| HSALNT0246388 | DCXR-DT | _ | _ | _ | prostate cancer | Male Urogenital Diseases |
| HSALNT0209659 | NKX2-1-AS1 | _ | _ | _ | lung cancer | Respiratory Tract Diseases |
| HSALNT0038250 | ACTR3-AS1 | _ | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0043145 | ITGA6-AS1 | _ | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0281822 | LINC02601 | _ | _ | _ | glioblastoma | Nervous system diseases |
| _ | ZKSCAN7-AS1 | _ | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0120721 | GARS-DT | _ | _ | _ | heroine addiction | Nervous system diseases |
| HSALNT0093136 | LINCADL | _ | _ | _ | obesity | Digestive system Diseases |
| _ | GPRACR | _ | _ | _ | liver cancer | Digestive system Diseases |
| HSALNT0082561 | LINC01060 | _ | _ | _ | pancreatic cancer | Digestive system Diseases |
| HSALNT0058704 | TBILA | _ | _ | _ | non-small cell lung cancer | Respiratory Tract Diseases |
| _ | UGDH-AS1 | _ | _ | _ | invertebral disc degeneration | Musculoskeletal Diseases |
| HSALNT0245777 | TNRC6C-AS1 | _ | _ | _ | Thyroid cancer | Endocrine system Disease |
| HSALNT0225753 | LINC02244 | _ | _ | _ | obesity | Digestive system Diseases |
| _ | NKAIN3-IT1 | _ | _ | _ | glioblastoma | Nervous system diseases |
| HSALNT0013113 | NGF-AS1 | _ | _ | _ | dysmenorhea | Female Urogenital Diseases |
| HSALNT0031057 | LINC01121 | _ | _ | _ | pancreatic cancer | Digestive system Diseases |
| HSALNT0234176 | ARLNC1 | _ | _ | _ | prostate cancer | Male Urogenital Diseases |
| _ | MPPED2-AS1 | _ | _ | _ | thyroid neoplasias | Endocrine system Disease |
| _ | ZKSCAN2-DT | _ | _ | _ | Hepatocellular carcinoma | Digestive system Diseases |
| _ | LINC01703 | _ | _ | _ | Hepatocellular carcinoma | Digestive system Diseases |
| HSALNT0144162 | HPYR1 | _ | _ | pathogenic process | H. pylori infection | _ |
| HSALNT0172266 | LINC00958 | _ | protein localization,transcriptional regulation | pathogenic process | bladder cancer, glioma | _ |
| HSALNT0167574 | SH3PXD2A-AS1 | _ | transcriptional regulation | pathogenic process | colorectal cancer | _ |
| _ | SSTR5-AS1 | _ | transcriptional regulation | pathogenic process | neuroendocrine prostate cancer | _ |
| _ | TSPOAP1-AS1 | _ | _ | pathogenic process | breast cancer | _ |
| _ | LINC00174 | _ | ceRNA | pathogenic process | colorectal carcinoma | _ |
| HSALNT0169064 | LINC01561 | _ | ceRNA | pathogenic process | breast cancer | _ |
| _ | LINC00514 | _ | transcriptional regulation | pathogenic process | neuroendocrine prostate cancer | _ |
| HSALNT0282164 | LINC02595 | _ | _ | pathogenic process | colorectal cancer | _ |
| HSALNT0197396 | FZD10-AS1 | _ | _ | _ | _ | _ |
| _ | LINC01567 | _ | transcriptional regulation | pathogenic process | colon cancer | _ |
| _ | ADPGK-AS1 | _ | transcriptional regulation | pathogenic process | pancreatic cancer | _ |
| HSALNT0255381 | RAB11B-AS1 | _ | transcriptional regulation | pathogenic process | osteosarcoma | _ |
| HSALNT0237805 | SNHG29 | _ | transcriptional regulation | pathogenic process | acute myeloid leukemia, rheumatoid arthritis | _ |
| _ | SNHG17 | _ | transcriptional regulation | pathogenic process | colorectal cancer | _ |
| HSALNT0215138 | DICER1-AS1 | _ | transcriptional regulation | pathogenic process | osteosarcoma | _ |
| HSALNT0043929 | TTN-AS1 | _ | transcriptional regulation | pathogenic process | esophageal squamous cell carcinoma | _ |
| HSALNT0152594 | LINC00092 | _ | transcriptional regulation | pathogenic process | ovarian cancer | _ |
| HSALNT0050704 | THUMPD3-AS1 | _ | transcriptional regulation | pathogenic process | Neuron death in stroke | _ |
| HSALNT0205980 | LINC00554 | _ | transcriptional regulation | pathogenic process | liver cancer | _ |
| HSALNT0141703 | ZFPM2-AS1 | _ | transcriptional regulation | pathogenic process | multiple cancers, gastric carcinogenesis | _ |
| _ | HOXB-AS1 | _ | transcriptional regulation | pathogenic process | autosomal dominant polycistic kidney disease | _ |
| HSALNT0167650 | CFAP58-DT | _ | transcriptional regulation | pathogenic process | innate immune response to viral infection | _ |
| _ | FAM230A | _ | _ | _ | _ | _ |
| _ | CPNE8-AS1 | _ | transcriptional regulation | pathogenic process | cervical cancer | _ |
| _ | THORLNC | _ | transcriptional regulation | pathogenic process | melanoma, skin squamous cell carcinoma,osteosarcoma, renal cell carcinoma | _ |
| _ | IATPR | _ | transcriptional regulation | pathogenic process | breast cancer, gallbladder cancer | _ |
| HSALNT0242280 | PICART1 | _ | transcriptional regulation | pathogenic process | breast cancer, colorectal cancer, lung cancer | _ |
| _ | LINC02599 | _ | transcriptional regulation | pathogenic process | breast cancer | _ |
| HSALNT0183231 | ETS1-AS1 | _ | transcriptional regulation | pathogenic process | gastric cancer, neuroblastoma | _ |
| _ | MAPK6-DT | _ | transcriptional regulation | pathogenic process | liver cancer | _ |
| HSALNT0036655 | IL1R1-AS1 | _ | transcriptional regulation | pathogenic process | Oral squamous cell carcinoma, breast cancer | _ |
| HSALNT0001134 | LINC01672 | _ | transcriptional regulation | pathogenic process | Esophageal squamous cell carcinoma | _ |
| HSALNT0135857 | SIRLNT | _ | ceRNA | pathogenic process | Breast cancer | _ |
| HSALNT0135484 | LINC01605 | _ | transcriptional regulation | pathogenic process | Colon Cancer, Bladder cancer | _ |
| HSALNT0184552 | GAU1 | _ | transcriptional regulation | pathogenic process | Neuroblastoma and retinoblastoma | _ |
| HSALNT0287294 | LINC00894 | _ | transcriptional regulation | pathogenic process | Lung adenocarcinoma | _ |
| HSALNT0000250 | LINC02593 | _ | _ | pathogenic process | breast cancer, hepatocellular carcinoma | _ |
| HSALNT0241060 | LINC02594 | _ | _ | _ | gastric cancer | _ |
| HSALNT0022481 | LINC01705 | _ | transcriptional regulation | pathogenic process | gastric cancer | _ |
| HSALNT0022477 | LINC02474 | _ | transcriptional regulation | pathogenic process | gastric cancer | _ |
| HSALNT0030809 | LINC02590 | _ | transcriptional regulation | pathogenic process | gastric cancer | _ |
| HSALNT0170966 | MUC5B-AS1 | _ | transcriptional regulation | pathogenic process | lung adenocarcinoma | _ |
| HSALNT0275151 | FAM230D | _ | _ | _ | _ | _ |
| HSALNT0275163 | FAM230E | _ | _ | _ | _ | _ |
| HSALNT0275179 | FAM230F | _ | _ | _ | _ | _ |
| _ | FAM230G | _ | _ | _ | _ | _ |
| _ | FAM230H | _ | _ | _ | Papillary thyroid carcinoma | _ |
| _ | FAM230I | _ | _ | _ | _ | _ |
| HSALNT0275150 | FAM230J | _ | _ | _ | _ | _ |
| HSALNT0103387 | HCG14 | _ | transcriptional regulation | pathogenic process | Celiac disease, Nutritional and Metabolic Diseases | _ |
| HSALNT0001419 | LNCTAM34A | _ | ceRNA | developmental process | Colon Cancer | _ |
| _ | LINC01510 | _ | transcriptional regulation, ceRNA | pathogenic process | Colorectal cancer, Non-small cell lung cancer | _ |
| _ | LNCOC1 | _ | transcriptional regulation | pathogenic process | Ovarian cancer | _ |
| _ | LGALSL-DT | _ | transcriptional regulation | pathogenic process | Postmenopausal osteoporosis (PMOP) | _ |
| HSALNT0002862 | LINC02596 | _ | transcriptional regulation | pathogenic process | Postmenopausal osteoporosis (PMOP) | _ |
| _ | DEC1 | _ | _ | _ | _ | _ |
| _ | RN7SK | _ | _ | _ | _ | _ |
| _ | RN7SL1 | _ | _ | _ | _ | _ |
| _ | MYOPARR | _ | _ | _ | _ | _ |
| _ | PCED1B-AS1 | _ | _ | _ | _ | _ |
| _ | UMLILO | _ | _ | _ | _ | _ |
| _ | LINC02631 | _ | _ | _ | _ | _ |
| _ | BMNCR | _ | _ | _ | _ | _ |
| _ | ZEBTR | _ | _ | _ | _ | _ |
| _ | SNHG31 | _ | _ | _ | _ | _ |
| _ | ILF3-DT | _ | _ | _ | _ | _ |
| _ | LINC00574 | _ | _ | _ | _ | _ |
| _ | CEBPA-DT | _ | _ | _ | _ | _ |
| _ | BABAM2-AS1 | _ | _ | _ | _ | _ |
| _ | [[]] | _ | _ | _ | _ | _ |
| _ | SNHG30 | _ | _ | _ | _ | _ |
| _ | RCC2-AS1 | _ | _ | _ | _ | _ |
| _ | NIPBL-DT | _ | _ | _ | _ | _ |
| _ | PRDM16-DT | _ | _ | _ | _ | _ |
| _ | BCL6-AS1 | _ | _ | _ | _ | _ |
| _ | C1orf220 | _ | _ | _ | _ | _ |
| _ | MIR122HG | _ | _ | _ | _ | _ |
| _ | RB1-DT | _ | _ | _ | _ | _ |
| _ | PANTR1 | _ | _ | _ | _ | _ |
| _ | C11orf72 | _ | _ | _ | _ | _ |
| _ | CT66 | _ | _ | _ | _ | _ |
| _ | CAPN10-DT | _ | _ | _ | _ | _ |
| _ | MIR1915HG | _ | _ | _ | _ | _ |
| _ | CT75 | _ | _ | _ | _ | _ |
| _ | [[]] | _ | _ | _ | _ | _ |
| _ | MIR9-3HG | _ | _ | _ | _ | _ |
| _ | RN7SL2 | _ | _ | _ | _ | _ |
| _ | RN7SL3 | _ | _ | _ | _ | _ |
| _ | CT70 | _ | _ | _ | _ | _ |
| _ | CT69 | _ | _ | _ | _ | _ |
| _ | FLVCR1-DT | _ | _ | _ | _ | _ |
| _ | C10orf91 | _ | _ | _ | _ | _ |
| _ | CEP83-DT | _ | _ | _ | _ | _ |
| _ | CSTF3-DT | _ | _ | _ | _ | _ |
| _ | CTBP1-DT | _ | _ | _ | _ | _ |
| _ | FAM201B | _ | _ | _ | _ | _ |
| _ | MAFG-DT | _ | _ | _ | _ | _ |
| _ | RPP38-DT | _ | _ | _ | _ | _ |
| _ | CDRT3 | _ | _ | _ | _ | _ |
| _ | DLEU2L | _ | _ | _ | _ | _ |
